Drug Policy

Cannabis Legalization Cannabis Regulation Marijuana Marijuana Legalization Marijuana Rescheduling Drug Classification Legislation Marijuana Classification Marijuana Reclassification Harm Reduction

Europe’s Drug Market Shifts to Domestic ‘Bath Salts’ and Potent Opioids

Laboratories in Poland are supplanting imports with potent cathinones alongside rising nitazene opioids that drive overdose spikes.

Munich Police Seize Nearly 1,500 Cannabis Plants in Major Raid

US Raids Disrupt Sinaloa Cartel’s Fentanyl Operations with 16 Arrests

Germany Faces Rising Threat from Potent Synthetic Opioids

France Launches Crackdown on Drug Use Amid Record Cocaine Seizures

Cocaine Use in France Nearly Doubles in 2023, Reaching 1.1 Million Users

Cocaine Use in France Nearly Doubles to 1.1 Million Annual Users in 2023

UK Considers Reclassifying Ketamine as Class A Drug

UK Government Orders Review to Reclassify Ketamine as Class A Drug

Crack Epidemic Expands Across Germany's Major Cities

Massive ₹1,814 Crore Drug Bust in Bhopal Sparks Political Uproar

Halifax Wastewater Reveals High Cannabis Use

West Virginia's New Drug Czar Brings Personal Experience to Opioid Crisis Fight

Trump and Harris Align on Marijuana Legalization as Key Election Issue

Biden Administration Moves to Reclassify Marijuana in Major Drug Policy Shift

U.S. Moves to Reclassify Marijuana, Potentially Easing State Legalization Efforts

Biden Administration Plans to Reschedule Marijuana to Schedule III Amid Ongoing Debates

Thailand to Ban Recreational Cannabis Amid Public Pressure

Democratic Senators Urge DEA to Fully Legalize Cannabis

FDA Recommends Reclassifying Marijuana Under Less Strict Federal Drug Laws